NCT07469826

Brief Summary

This study looked at two different medicines used during local anesthesia to control pain after surgery. Investigators compared bupivacaine alone with bupivacaine mixed with tramadol. Both medicines are commonly used to numb the surgical area and reduce pain. The investigators included 100 adult patients who had minor surgeries under local anesthesia. Half received only bupivacaine, and the other half received bupivacaine combined with tramadol. After surgery, patients were asked to rate their pain at 4, 8, and 24 hours. The results showed that patients who received bupivacaine with tramadol felt less pain, especially at 24 hours after surgery, compared to those who received bupivacaine alone. In simple words: Adding tramadol to bupivacaine helps reduce pain better than bupivacaine alone. This method may help patients recover faster, feel more comfortable, and need fewer pain medicines after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Oct 2022

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2023

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 13, 2026

Completed
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

December 22, 2025

Last Update Submit

March 9, 2026

Conditions

Keywords

BupivacaineTramadolPost operative pain

Outcome Measures

Primary Outcomes (1)

  • Mean postoperative pain score

    Mean postoperative pain score using the visual analog scale at 4,8 and 24 hours postoperatively. Visual Analog Scale (VAS) is a 10-cm horizontal line ranging from 0 (no pain) to 10 (worst imaginable pain). Patients will mark the point representing their pain intensity. Scores will be recorded at predetermined postoperative intervals.

    Patients were monitored for 24 hours immediately following the completion of the surgical procedure

Study Arms (2)

Use of Bupivacaine alone for treating postoperative pain

ACTIVE COMPARATOR
Drug: Bupivacaine

Use of Bupivacaine and Tramadol together for treating postoperative pain

EXPERIMENTAL
Drug: TramadolDrug: Bupivacaine

Interventions

A single dose of 1 mg/kg tramadol at the surgical site

Use of Bupivacaine and Tramadol together for treating postoperative pain

Single dose 0.5 ml/kg of 0.25% Bupivacaine at surgical site

Use of Bupivacaine alone for treating postoperative painUse of Bupivacaine and Tramadol together for treating postoperative pain

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All patients undergoing elective procedure under local anesthesia
  • Either gender.
  • Age 18-60 years.

You may not qualify if:

  • Procedures Under general anesthesia.
  • Diabetic patients, assessed by history and clinically and HbA1c \>6.5%
  • Patients with metastatic disease, assessed by history, clinically and by imaging.
  • Patients who are I/V opioid abusers will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jinnah postgraduate medical university

Karachi, Sindh, 75510, Pakistan

Location

Related Publications (10)

  • Malik AI, Sheikh IA, Qasmi SA, Adnan A. Comparison of tramadol with bupivacaine as local anaesthetic in postoperative pain control. Journal of Surgery Pakistan (International). 2011 Jan;16(1):10-3.

    BACKGROUND
  • Khan S, Memon MI. Comparison of caudal bupivacaine and bupivacaine-tramadol for postoperative analgesia in children with hypospadias repair. J Coll Physicians Surg Pak. 2008 Oct;18(10):601-4. doi: 10.2008/JCPSP.601604.

    PMID: 18940114BACKGROUND
  • Passavanti MB, Piccinno G, Alfieri A, Di Franco S, Sansone P, Mangoni G, Pota V, Aurilio C, Pace MC, Fiore M. Local infiltration of tramadol as an effective strategy to reduce post-operative pain: a systematic review protocol and meta-analysis. Syst Rev. 2020 Jul 13;9(1):157. doi: 10.1186/s13643-020-01419-1.

    PMID: 32660546BACKGROUND
  • Kelley BP, Shauver MJ, Chung KC. Management of Acute Postoperative Pain in Hand Surgery: A Systematic Review. J Hand Surg Am. 2015 Aug;40(8):1610-9, 1619.e1. doi: 10.1016/j.jhsa.2015.05.024.

    PMID: 26213198BACKGROUND
  • Obsa MS, Andebirku AA, Gemechu AD, Haile KE. Effectiveness of tramadol with bupivacaine versus bupivacaine alone on postoperative analgesia at Wolaita Sodo, southern Ethiopia: Observational Cohort Study. 2021

    BACKGROUND
  • Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016 Feb;17(2):131-57. doi: 10.1016/j.jpain.2015.12.008.

    PMID: 26827847BACKGROUND
  • Jenkins NW, Parrish JM, Mayo BC, Hrynewycz NM, Brundage TS, Mogilevsky FA, Yoo JS, Singh K. The identification of risk factors for increased postoperative pain following minimally invasive transforaminal lumbar interbody fusion. Eur Spine J. 2020 Jun;29(6):1304-1310. doi: 10.1007/s00586-020-06344-4. Epub 2020 Feb 19.

    PMID: 32076833BACKGROUND
  • Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017 Sep 25;10:2287-2298. doi: 10.2147/JPR.S144066. eCollection 2017.

    PMID: 29026331BACKGROUND
  • Kuusniemi K, Poyhia R. Present-day challenges and future solutions in postoperative pain management: results from PainForum 2014. J Pain Res. 2016 Feb 3;9:25-36. doi: 10.2147/JPR.S92502. eCollection 2016.

    PMID: 26893579BACKGROUND
  • Labrum JT 4th, Ilyas AM. Preemptive Analgesia in Thumb Basal Joint Arthroplasty: Immediate Postoperative Pain with Preincision versus Postincision Local Anesthesia. J Hand Microsurg. 2017 Aug;9(2):80-83. doi: 10.1055/s-0037-1603734. Epub 2017 Jun 5.

    PMID: 28867907BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Interventions

TramadolBupivacaine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

CyclohexanolsHexanolsFatty AlcoholsAlcoholsOrganic ChemicalsDimethylaminesMethylaminesAminesLipidsAnilidesAmidesAniline Compounds

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 22, 2025

First Posted

March 13, 2026

Study Start

October 10, 2022

Primary Completion

April 10, 2023

Study Completion

May 10, 2023

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual Participant Data (IPD) will not be shared because the dataset contains potentially identifiable clinical information collected from a relatively small study population. Participants did not provide explicit consent for public data sharing beyond the purposes of this study. In addition, the data are being used solely for predefined analyses, and there are no current plans for secondary analyses requiring external data access. Aggregate results will be published to ensure transparency while maintaining participant confidentiality.

Locations